|
EB病毒与肺部疾病关系的研究进展
|
Abstract:
EB病毒是一种传染性病毒,能够引起多种原发感染,导致并发症,并诱发各种恶性肿瘤,给人们的生命健康带来极大威胁。1964年Epstein和Barr在非洲儿童恶性淋巴瘤的细胞培养物中发现了EB病毒,其发现标志着人类疱疹病毒研究领域的重要突破。此病毒广泛存在于人群中,大部分感染者无明显症状,少数成人感染可表现为传染性单核细胞增多症。然而越来越多的研究证明EB病毒与呼吸系统疾病也存在关联,影响多种呼吸系统疾病的发生、发展,影响疾病的预后,与病情程度密切相关。本文旨在对肺部疾病与EB病毒关系的研究进展进行综述,详细阐述EB病毒的感染机制、影像学,深入探讨其与慢性阻塞性肺疾病、肺癌、肺炎等常见肺部疾病的相关性以及治疗和预后,并对未来的研究方向进行展望,旨在提高人们对EB病毒导致肺部疾病的认识,为肺部疾病的临床诊断、治疗及预防提供新的思路和理论依据。
Epstein-Barr (EB) virus is a contagious virus that can cause a variety of primary infections, leading to complications and inducing various malignant tumors, posing a significant threat to human health. In 1964, Epstein and Barr discovered EB virus in cell cultures of African children with malignant lymphoma, marking a significant breakthrough in the field of human herpesvirus research. This virus is widely present in the human population, with most infected individuals showing no obvious symptoms. However, a minority of adult infections may manifest as infectious mononucleosis. Increasing evidence has shown that EB virus is also associated with respiratory diseases, influencing the occurrence, development, prognosis, and severity of various respiratory conditions. This review aims to summarize the research progress on the relationship between pulmonary diseases and EB virus, elaborating on the infection mechanisms and imaging characteristics of EB virus, and exploring its associations with common pulmonary diseases such as chronic obstructive pulmonary disease (COPD), lung cancer, and pneumonia, as well as treatment and prognosis. Future research directions are also discussed, with the goal of enhancing the understanding of pulmonary diseases caused by EB virus and providing new insights and theoretical foundations for the clinical diagnosis, treatment, and prevention of pulmonary diseases.
[1] | 李巧. 传染性单核细胞增多症发病机制研究[J]. 中国疗养医学, 2022, 31(2): 154-156. |
[2] | 姜涵毅, 赵婷婷, 肖永龙, 等. 结缔组织病相关间质性肺疾病合并EB病毒血症患者临床病理参数及危险因素分析[J]. 临床检验杂志, 2025, 43(3): 174-178. |
[3] | Osorio, J.C., Blanco, R., Corvalán, A.H., Muñoz, J.P., Calaf, G.M. and Aguayo, F. (2022) Epstein-Barr Virus Infection in Lung Cancer: Insights and Perspectives. Pathogens, 11, Article 132. https://doi.org/10.3390/pathogens11020132 |
[4] | Becnel, D., Abdelghani, R., Nanbo, A., Avilala, J., Kahn, J., Li, L., et al. (2021) Pathogenic Role of Epstein-Barr Virus in Lung Cancers. Viruses, 13, Article 877. https://doi.org/10.3390/v13050877 |
[5] | Zhou, Y., Jiang, J., He, S., Li, Y., Cheng, X., Liu, S., et al. (2025) Epstein-Barr Virus Hijacks Histone Demethylase Machinery to Drive Epithelial Malignancy Progression through KDM5B Upregulation. Signal Transduction and Targeted Therapy, 10, Article No. 83. https://doi.org/10.1038/s41392-025-02163-5 |
[6] | Tan, B., Xu, K., Lyu, Y., Liang, Y., Liang, R., Lei, K., et al. (2025) Single-cell Analysis Reveals Transcriptomic Features and Therapeutic Targets in Primary Pulmonary Lymphoepithelioma-Like Carcinoma. Communications Biology, 8, Article No. 394. https://doi.org/10.1038/s42003-025-07819-0 |
[7] | Joo, E., Ha, Y.E., Jung, D.S., Cheong, H.S., Wi, Y.M., Song, J., et al. (2011) An Adult Case of Chronic Active Epstein-Barr Virus Infection with Interstitial Pneumonitis. The Korean Journal of Internal Medicine, 26, 466-469. https://doi.org/10.3904/kjim.2011.26.4.466 |
[8] | 何馨, 姚志刚, 符玉环, 等. EB病毒感染所致肺部感染患者的胸部高分辨CT特征分析[J]. 北京医学, 2022, 44(3): 236-240. |
[9] | 张正玲, 张翊玲, 路苹, 等. EB病毒感染对慢性阻塞性肺疾病急性加重期炎症反应影响41例临床研究[J]. 中国实用内科杂志, 2019, 39(2): 153-157. |
[10] | 胡晓飞, 许世佳, 薛河东. 慢性阻塞性肺疾病急性加重期患者相关病毒感染情况分析[J]. 中国卫生检验杂志, 2022, 32(11): 1343-1345. |
[11] | Chen, Y., Liu, T., Xu, Z. and Dong, M. (2023) Association of Epstein-Barr Virus (EBV) with Lung Cancer: Meta-Analysis. Frontiers in Oncology, 13, Article 1177521. https://doi.org/10.3389/fonc.2023.1177521 |
[12] | Koshiol, J., Gulley, M.L., Zhao, Y., Rubagotti, M., Marincola, F.M., Rotunno, M., et al. (2011) Epstein-Barr Virus MicroRNAs and Lung Cancer. British Journal of Cancer, 105, 320-326. https://doi.org/10.1038/bjc.2011.221 |
[13] | Xie, M., Wu, X., Wang, F., Zhang, J., Ben, X., Zhang, J., et al. (2018) Clinical Significance of Plasma Epstein-Barr Virus DNA in Pulmonary Lymphoepithelioma-Like Carcinoma (LELC) Patients. Journal of Thoracic Oncology, 13, 218-227. https://doi.org/10.1016/j.jtho.2017.10.031 |
[14] | 桑艳峰, 孟林, 冯会颖, 等. EB病毒感染相关肺炎患儿的临床特征分析[J]. 中华医院感染学杂志, 2020, 30(9): 1407-1411. |
[15] | 肖逸, 张凌云, 曾朝阳, 等. 成人EB病毒性肺炎合并EB病毒性脑炎一例报告[J]. 中国感染控制杂志, 2022, 21(7): 686-689. |
[16] | 李勇超, 宋丹丹, 于智勤, 等. 重症肺炎支原体肺炎合并EB病毒感染的临床及实验室特征[J]. 检验医学与临床, 2024, 21(11): 1568-1572, 1578. |
[17] | 王超颖, 方洁, 郭盛, 等. 肺炎支原体肺炎合并EB病毒感染41例临床分析[J]. 中华全科医学, 2016, 14(8): 1252-1254. |
[18] | 解玲玲, 孙亚娜, 吴良霞. 肺炎支原体肺炎合并Epstein-Barr病毒感染患儿的血清因子及免疫分析[J]. 微生物与感染, 2018, 13(5): 278-283. |
[19] | 杨大伟. EB病毒及人巨细胞病毒感染与狼疮性胸膜肺损害的相关性研究[D]: [硕士学位论文]. 福州: 福建医科大学, 2014. |
[20] | 胡桂凤, 高爱梅. 更昔洛韦与阿奇霉素联合治疗EB病毒合并肺炎支原体感染的疗效分析[J]. 检验医学与临床, 2023, 20(20): 2978-2981. |
[21] | 王聪, 蒋菊华, 朱丹丹. 人免疫球蛋白联合糖皮质激素治疗小儿肺炎支原体伴EB病毒感染的临床价值[J]. 实用中西医结合临床, 2023, 23(19): 31-34. |
[22] | 杨栖, 王春语, 李思儒, 等. 原发性肺淋巴上皮瘤样癌45例临床分析[J]. 中国呼吸与危重监护杂志, 2023, 22(7): 500-505. |
[23] | 顾旭华, 陈颖, 张海涛. 健脾补肺汤联合阿昔洛韦注射液治疗小儿呼吸道EB病毒感染疗效研究[J]. 陕西中医, 2023, 44(12): 1730-1734. |
[24] | 林志潮. 可手术的原发性肺淋巴上皮瘤样癌的临床及病理分析研究[D]: [博士学位论文]. 广州: 南方医科大学, 2016. |
[25] | 李芳, 程莉莎, 甘荷霞, 等. 原发性肺淋巴上皮瘤样癌的临床特征及预后[J]. 中国临床医学, 2022, 29(6): 957-961. |
[26] | Sun, C., Kang, Y., Fang, X., Liu, Y., Bu, G., Wang, A., et al. (2023) A Gb Nanoparticle Vaccine Elicits a Protective Neutralizing Antibody Response against EBV. Cell Host & Microbe, 31, 1882-1897.e10. https://doi.org/10.1016/j.chom.2023.09.011 |
[27] | Dasari, V., McNeil, L.K., Beckett, K., Solomon, M., Ambalathingal, G., Thuy, T.L., et al. (2023) Lymph Node Targeted Multi-Epitope Subunit Vaccine Promotes Effective Immunity to EBV in Hla-Expressing Mice. Nature Communications, 14, Article No. 4371. https://doi.org/10.1038/s41467-023-39770-1 |
[28] | Sun, C., Fang, X., Bu, G., Zhong, L., Xie, C., Zhao, G., et al. (2025) Structural Basis of Epstein-Barr Virus Gp350 Receptor Recognition and Neutralization. Cell Reports, 44, Article ID: 115168. https://doi.org/10.1016/j.celrep.2024.115168 |
[29] | Zhong, L., Krummenacher, C., Zhang, W., Hong, J., Feng, Q., Chen, Y., et al. (2022) Urgency and Necessity of Epstein-Barr Virus Prophylactic Vaccines. npj Vaccines, 7, Article No. 159. https://doi.org/10.1038/s41541-022-00587-6 |
[30] | Cui, X. and Snapper, C.M. (2021) Epstein Barr Virus: Development of Vaccines and Immune Cell Therapy for EBV-Associated Diseases. Frontiers in Immunology, 12, Article 734471. https://doi.org/10.3389/fimmu.2021.734471 |
[31] | Wei, C., Bu, W., Nguyen, L.A., Batchelor, J.D., Kim, J., Pittaluga, S., et al. (2022) A Bivalent Epstein-Barr Virus Vaccine Induces Neutralizing Antibodies That Block Infection and Confer Immunity in Humanized Mice. Science Translational Medicine, 14, eabf3685. https://doi.org/10.1126/scitranslmed.abf3685 |